From helping our immune system stop tumour growth to improving the quality of life of patients, Queen’s researchers are being recognized for their groundbreaking work on cancer biology, treatment, and care.
Cancer research programs led by Dr. Sébastien Talbot (Biomedical and Molecular Sciences) and Dr. Brooke Wilson (Medical Oncology) were awarded new funding from the Canadian Cancer Society (CCS).
The Queen’s Health Sciences researchers received Emerging Scholar Research Grants worth a combined $1.1M over five years to “support promising early-career investigators from across Canada” to “pursue important scientific advances” of the highest quality.
Dr. Talbot ’s lab is working to boost immunosurveillance and improve chances of survival for people with cancer. The immune system inherently identifies and eliminates abnormal cells, including cancer cells. However, under this immune pressure, cancer can evolve to evade this detection, allowing tumour cells to continue growing unchecked. When cancer adapts in this way, it gains the ability to sustain its growth despite the immune system’s efforts.
Read the full story in the Gazette